Otrivine Junior Tegen Neusverstopping (Xylometazoline Hydrochloride)

Otrivine Junior Tegen Neusverstopping contains xylometazoline, a nasal decongestant that acts on the upper‑respiratory tract to reduce swelling of nasal mucosa.

• Common cold: provides temporary relief of nasal blockage in children.
• Allergic rhinitis: eases congestion caused by seasonal or perennial allergens.
• Acute sinusitis: helps open nasal passages during the early phase of sinus inflammation.

• Xylometazoline hydrochloride binds to alpha‑2 adrenergic receptors on the smooth muscle of nasal blood vessels, causing vasoconstriction. This reduces blood flow to the nasal mucosa, decreasing edema and opening the airway for easier breathing.

Side effects are generally mild and related to local irritation of the nasal mucosa.

Common Side Effects

• Nasal burning or stinging sensation.
• Mild headache.
• Dryness of the nasal passages.
• Sneezing shortly after application.
• Transient taste disturbance.
• Mild epistaxis (nosebleed).

Serious or Rare Side Effects

• Persistent nasal irritation or ulceration.
• Severe or prolonged nosebleeds.
• Allergic reaction such as rash, itching or swelling of the face.
• Difficulty breathing due to swelling of the airway.
• Hypertensive crisis in susceptible individuals.
• Rebound congestion after prolonged use (>3‑5 days).

Before using Otrivine Junior, consider the following safety measures:

• Age restriction: use only in children as directed by a healthcare professional.
• Duration limit: do not exceed the recommended treatment period, typically up to 3‑5 days.
• Pre‑existing conditions: avoid if the child has severe hypertension, heart disease, or thyroid disorders.
• Concomitant nasal medications: do not combine with other topical decongestants without medical advice.
• Pregnancy & lactation: consult a physician before use in pregnant or breastfeeding mothers.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medicines that affect vascular tone or blood pressure.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive reactions.
• Systemic alpha‑adrenergic agonists: additive vasoconstrictive effects.

Moderate Interactions (Monitor Closely)

• Nasal corticosteroids: monitor for increased local irritation.
• Antihistamines: may enhance drying of nasal mucosa.
• Antihypertensive drugs: observe for unexpected blood pressure changes.
• Herbal decongestants (e.g., ephedrine): potential additive effects.